19-32738955-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001366102.1(TDRD12):c.283G>A(p.Val95Met) variant causes a missense change. The variant allele was found at a frequency of 0.000184 in 1,550,778 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00011 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00019 ( 0 hom. )
Consequence
TDRD12
NM_001366102.1 missense
NM_001366102.1 missense
Scores
5
4
9
Clinical Significance
Conservation
PhyloP100: 5.19
Genes affected
TDRD12 (HGNC:25044): (tudor domain containing 12) Predicted to enable ATP binding activity; RNA helicase activity; and nucleic acid binding activity. Predicted to be involved in several processes, including gamete generation; gene silencing by RNA; and piRNA metabolic process. Predicted to be part of PET complex. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.3759652).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TDRD12 | NM_001366102.1 | c.283G>A | p.Val95Met | missense_variant | 3/33 | ENST00000639142.2 | NP_001353031.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TDRD12 | ENST00000639142.2 | c.283G>A | p.Val95Met | missense_variant | 3/33 | 5 | NM_001366102.1 | ENSP00000492643.2 | ||
TDRD12 | ENST00000444215.6 | c.283G>A | p.Val95Met | missense_variant | 3/28 | 1 | ENSP00000416248.2 | |||
TDRD12 | ENST00000647536.1 | c.283G>A | p.Val95Met | missense_variant | 3/33 | ENSP00000496698.1 | ||||
TDRD12 | ENST00000421545.2 | c.283G>A | p.Val95Met | missense_variant | 3/13 | 5 | ENSP00000390621.2 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152220Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
17
AN:
152220
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000638 AC: 10AN: 156690Hom.: 0 AF XY: 0.0000723 AC XY: 6AN XY: 83034
GnomAD3 exomes
AF:
AC:
10
AN:
156690
Hom.:
AF XY:
AC XY:
6
AN XY:
83034
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000192 AC: 268AN: 1398558Hom.: 0 Cov.: 30 AF XY: 0.000197 AC XY: 136AN XY: 689796
GnomAD4 exome
AF:
AC:
268
AN:
1398558
Hom.:
Cov.:
30
AF XY:
AC XY:
136
AN XY:
689796
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000112 AC: 17AN: 152220Hom.: 0 Cov.: 33 AF XY: 0.0000807 AC XY: 6AN XY: 74370
GnomAD4 genome
AF:
AC:
17
AN:
152220
Hom.:
Cov.:
33
AF XY:
AC XY:
6
AN XY:
74370
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
3
ExAC
AF:
AC:
3
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 30, 2024 | The c.283G>A (p.V95M) alteration is located in exon 3 (coding exon 3) of the TDRD12 gene. This alteration results from a G to A substitution at nucleotide position 283, causing the valine (V) at amino acid position 95 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Benign
T;.;.
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T;T
M_CAP
Benign
D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;.;D
REVEL
Uncertain
Sift
Uncertain
D;.;D
Sift4G
Pathogenic
D;.;D
Polyphen
D;.;.
Vest4
MVP
ClinPred
T
GERP RS
Varity_R
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at